Pharmacology and efficacy of cyclooxygenase (COX) inhibitors-Reference-Cited by-同舟云学术

Pharmacology and efficacy of cyclooxygenase (COX) inhibitors

Published:1999-12 Issue:6 Volume:107 Page:18-22
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Furst Daniel E

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Differential inhibition of cyclo-oxygenase-1 and -2 by meloxicam and its 4′ isomer;Pairet;Inflamm Res,1998

2. Cyclooxygenase 1 and 2;Vane;Annu Rev Pharmacol Toxicol,1998

3. Tissue selective inhibition of prostaglandin biosynthesis by etodolac;Dvornik;J Rheumatol Suppl,1997

4. Efficacy and gastric safety of etodolac as determined in cultured human gastric and synovial cells;Adams;Gastroenterology,1990

5. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthesis;Patrignani;J Pharmacol Exp Ther,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is informed consent necessary for randomized Phase IV ‘observational’ drug studies?;Drug Discovery Today;2011-06

2. The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes;International Immunopharmacology;2009-09

3. Management of Perioperative Pain;Surgery;2008

4. Non-steroidal anti-inflammatory drugs in Parkinson's disease;Experimental Neurology;2007-06

5. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): Molecular docking and 3D-QSAR analyses on DHDMBF analogues;Bioorganic & Medicinal Chemistry;2006-05